Open access peer-reviewed chapter

Kisspeptin: Role in Female Infertility

Written By

Abdulsamed Kükürt, Mushap Kuru, Ömer Faruk Başer and Mahmut Karapehlivan

Submitted: 26 October 2020 Reviewed: 05 November 2020 Published: 23 November 2020

DOI: 10.5772/intechopen.94925

From the Edited Volume

Reproductive Hormones

Edited by Courtney Marsh

Chapter metrics overview

748 Chapter Downloads

View Full Metrics


Kisspeptin is a neuropeptide encoded by the kisspeptin gene (Kiss1) and located in different brain regions, primarily in the hypothalamus. Kisspeptin and its receptor G-protein-coupled receptor-54 (GPR54), are also found in behavioural brain regions such as the hippocampus and cortex. Kisspeptin, a very powerful neuropeptide that stimulates the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary, does this by increasing gonadotropin-releasing hormone (GnRH) levels. In recent studies, it has been noted that kisspeptin is effective on reproductive functions. Globally 8 to 12% of couples have infertility problems, and the majority are residents of developing countries. Approximately 70% of infertility cases are caused by fertility problems in women. The frequency of infertility in women continues to increase every year and the underlying factors require further research. Bearing this problem in mind, this review examines the possible role of kisspeptin in female infertility. In doing so, it aims to find out how future application of kisspeptin may potentially unravel the neural reproductive disorder.


  • kisspeptin
  • metastin
  • GPR54
  • Kiss1
  • Kiss1r
  • infertility
  • nitric oxide
  • sex streoid
  • progesterone
  • GnRH
  • LH
  • FSH

1. Introduction

Infertility is the inability to get pregnant despite regular sexual intercourse for one year or more (without contraception or the impairment of a person’s or a couple’s fertility) [1]. Fertility and pregnancy rates decrease due to ageing in women. For this reason, it is recommended that women aged 35 and above start receiving infertility treatment after 6 months of conception attempt. After the age of 40, this period should not be waited for treatment. Many factors cause female infertility. These can be listed as medical history (family history, previous treatments, menstrual history, sexual history, etc.), physical factors (weight, body mass index, etc.), diminished ovarian reserves, ovulatory dysfunction (hypothalamic–pituitary axis (HPG axis) disorders, ovarian disorders, thyroid disorders and hyperprolactinemia, etc.), tubal factors, uterine factors and unexplained causes [2, 3]. More than 186 million people worldwide suffer from infertility, and the majority of them are residents of developing countries [4].

Kisspeptin was discovered in 1996 as the product of the kisspeptin gene (Kiss1), which is a metastatic tumour suppressor gene; therefore, it was initially called metastin [5]. Kisspeptins are a family of neuropeptides in RF-Amide structure [(neuropeptides containing arginine-phenylalanine (Arg-Phe) at the C-terminal are defined as RF-Amides)] [6]. Two years later, the connection between kisspeptin-54 and G-protein-coupled receptor-54 (GPR54) was shown for the first time [7]. In 2003, inactivating mutations of GPR54 were found in people with hypogonadotropic hypogonadism [8]. The respective receptor was previously called the GPR54, it is also identified as the kisspeptin receptor (Kiss1r) nowadays [9].

The detection of the role of the kisspeptin receptor mutation in leading to idiopathic hypogonadotropic hypogonadism paved the way for further investigations about the roles played by the kisspeptin, Kiss1, and Kiss1r systems in the field of reproductive endocrinology [10]. Many studies have shown that kisspeptin plays key roles in the regulation of different aspects of reproduction [11, 12, 13, 14, 15, 16, 17]. This review examines the possible role of kisspeptin in female infertility. In doing so, it aims to find out how future application of kisspeptin may potentially unravel the neural fertility disorder.


2. Kisspeptin

The Kiss1 gene encodes the neuropeptide kisspeptins. They, originally identified as metastasis suppressors, were later found to play a central regulatory role in reproduction [18]. The gene is located on human chromosome 1q32. This gene contains 2 non-expressed and 2 partially expressed regions and four exons, assembling the leader peptide consisting of 145 amino acids [19]. This precursor protein transforms into various active forms of kisspeptin with lengths of 54, 14, 13, and 10 amino acids through various post-translational modifications (Figure 1) [20]. These forms belong to the RF-amide peptide hormone family, which is closely associated with energy metabolism and reproduction. The members of the RF-amide peptide hormone family contain the common Arg-Phe-NH2 moiety at the C-terminal [21].

Figure 1.

Amino acids sequence of human kisspeptin isoforms [23, 24].

Kisspeptin receptors were first discovered in 2001 in studies about cancer, and they were named as the GPR54. Today, they are identified as the Kiss1r [9]. Kiss1r is a 396-amino acid receptor and a member of G protein-coupled receptors. The minimum length required to activate GPR54 is a 10-amino acid carboxyl terminal sequence (Kisspeptin-10) [22].


3. Kisspeptin’s mechanism of action

As a result of the kisspeptin binding to the GPR54/Kiss1r receptor, activates the G-protein (Gq/11) and phospholipase-C (PLC). Subsequently, diacylglycerol and inositol trisphosphate (IP3) are formed from phosphatidylinositol bisphosphate (PİP2), resulting in elevated Ca+2 concentrations. Activation of this mechanism results in the closure of the potassium channels and opening of the cation channels (TRP channels), leading to the depolarization of GnRH neurons. Consequently, GnRH neurons start secreting hormones [25]. Kisspeptin increase apoptosis and decrease cell proliferation and metastasis by stimulating the mitogen-activated protein kinase pathway (MAPK) via protein kinase C (PKC) and the extracellular signal-regulated kinase (ERK) pathway (Figure 2) [26].

Figure 2.

Cellular action mechanism of kisspeptins [27].


4. Distribution of kisspeptin neurons and effects on the HPG axis

Kisspeptin gene neurons are involved in several actions including steroid hormone feedback, metabolic signalling, and photoperiodic information regulation. It is suggested that, compatibly with their mediator role in steroid hormone feedback mechanisms, Kiss1 neurons are involved in the expression of estrogen receptors (ERα and ERβ) and progesterone receptors [21].

Kiss1 neurons are located in the periventricular nucleus (PeN), arcuate nucleus (ARC) and anteroventral periventricular nucleus (AVPV) which are located in the preoptic area of the hypothalamus (POA) in the brain and which are the regions that regulate the secretion of the GnRH hormone in mouse [28]. Kisspeptins are secreted by these nuclei. However, AVPV displays sexual dimorphism. Kiss1 mRNA expression is higher in AVPV in females compared to males. This indicates that the role of kisspeptin neurons in AVPV varies by gender [29].

The different patterns of Kiss1 mRNA regulation in the forebrain nuclei are important in the emergence of the different physiological effects of Kiss1 on the HPG axis. ARC acts as the negative feedback regulation centre for the GnRH and gonadotropin secretion, while AVPV acts as the positive feedback regulation centre responsible for the LH surge in females. ERα, ERβ, and progesterone receptors are abundant in AVPV. When these receptors bind to their ligands; they increase LH secretion, resulting in the LH surge. Furthermore, Kiss1 neurons in AVPV synapse with GnRH neurons; Kiss1 mRNA expression in AVPV peaks simultaneously with the GnRH/LH release, and the estrogen-dependent Kiss1 mRNA induction in females is involved in the GnRH/LH surge during preovulation [30]. While gonadal steroids inhibit Kiss1 neurons in ARC (negative feedback), they stimulate Kiss1 neurons in AVPV (positive feedback) [23]. Signals arising from kisspeptin binding to GPR54 receptors of the hypothalamic GnRH neurons induce the release of GnRH to the pituitary circulation. GnRH induces the release of gonadotropins (FSH, LH) from the pituitary by binding to the GnRH receptors in the pituitary gland (Figure 3) [31, 32].

Figure 3.

Kiss1 signalling in mouse brain [32].

The molecular mechanisms underlying the different effects of estrogen on the Kiss1 expression in ARC and AVPV is yet to be known. However, progesterone receptors are also thought to be involved in this phenomenon. Kiss1 neurons are colocalized with or stand very close to progesterone neurons in mouse. Tyrosine hydroxylase and Kiss1 mRNAs are colocalized in AVPV but not in ARC. Consequently, it is thought that dopamine is also involved in the induction of estrogen-dependent Kiss1 expression in AVPV [33].

In mouse, ARC Kiss1 neurons synthesize Tachykinin (TAC), neurokinin-B (NKB), and dynorphin (Dyn) in variable quantities depending on species; therefore, they are also known as KNDy (Kisspeptin/Neurokinin/Dynorphin) neurons. NKB and Dyn have been shown to mutually act on kisspeptin neurosecretion [34].


5. The effect of kisspeptin on puberty

The detection of the role of the kisspeptin receptor mutation in leading to idiopathic hypogonadotropic hypogonadism paved the way for studies to further investigate the other roles played by the Kisspeptin, Kiss1, and Kiss1r systems in the field of reproductive endocrinology [10]. The direct/indirect effects of kisspeptin on GnRH neurons leave no doubt that kisspeptin plays a critical role in pubertal activation. Indeed, studies on various species have shown that the Kiss1 and/or Kiss1r expression increases significantly with the onset of puberty [21]. In a study on mice, it was shown that the Kiss1 mRNA expression significantly increased in AVPV during puberty [35]. Also, centrally or peripherally administered kisspeptin in juvenile female rats shortened the timing of vaginal opening by stimulating LH release and ovulation [36, 37]. Similarly, the increase in kisspeptin-54 signal frequency in primates occur at the beginning of puberty, supporting the findings associated with the pubertal increase in kisspeptin secretion [38]. Kiss1 mRNA expression increases in ARC during puberty along with an associated increase in LH secretion in Rhesus monkeys [39].

Kisspeptin receptor damage impair normal sexual development and to result in the failure of starting puberty. Despite the synthesis of GnRH at normal levels in the hypothalamic GnRH neurons, LH/FSH secretions do not occur and pituitary gonadotropic cells remain unresponsive to externally administered GnRH in such cases [40]. The emergence of problems in the process of starting puberty in the presence of kisspeptin deficiencies has led to the idea that kisspeptin may be an important factor for the start of sexual maturation. This idea has been confirmed by significantly increased levels of released GnRH via kisspeptin injections in mammals and by the acceleration of pubertal start via repeated Kisspeptin injections in juvenile rats. Thus, it has been proven that Kisspeptin certainly participates in pubertal development [41].

A cerebral antibody binds and inactivates kisspeptin in the female rats, impairing or even stopping reproductive functions. Also, the administration of kisspeptin in fasted rats sustains the release of GnRH and that mammals suspend their reproductive functions during states of long-term hunger in order to spend energy only enough to maintain physiological requirements. Nonetheless, the administration of kisspeptin reverses this natural process and restarts reproductive functions [42].

Nitric oxide (NO) is another potential mediator that can affect the onset of puberty since it is a mediator involved in several vital functions such as gonadotropin release, steroidogenesis, folliculogenesis, ovulation, luteal development, luteolysis, and pregnancy [43, 44]. Neuronal nitric oxide synthase (nNOS) is one of the three forms of an enzyme that oxidizes L-arginine to L-citrulline and NO. nNOS neurons in mice and rats contain high densities of ERα [45]. In rats, NO stimulates LH and GnRH release. In mice, deletion of nNOS causes infertility and hypogonadism [46]. Furthermore, recent evidence suggests that kisspeptin may directly act on the release of NO. In adult female mice, kisspeptin close-contacts to nNOS neurons have been observed in the ARC and preoptic region; however, Kiss1r is expressed only from nNOS neurons in the preoptic region [47].


6. Kisspeptin in female infertility

Kisspeptin and neurokinin-B agonists can be used to stimulate the HPG axis in conditions associated with infertility due to central nervous system causes if the system of GnRH neurons is intact. Kisspeptin and neurokinin-B may offer a novel therapeutic approach to treat failures associated with increased/reduced gonadotropin pulsatile secretion. Kisspeptins may be associated with a lower risk of ovarian hyperstimulation syndrome (OHSS) compared to human chorionic gonadotropin (hCG) injections [48]. In polycystic ovary syndrome (PCOS), kisspeptin antagonists can help normalize LH hypersecretion along with ovulation and follicular development [49].

In a study on patients with unexplained infertility (UI), PCOS, and male factor infertility (MFI); In PCOS group kisspeptin levels were measured and found to be significantly higher compared to the MFI and UI groups. The investigators suggested that IU can be treated with kisspeptin injections and that high kisspeptin levels can be a reliable indicator to estimate the antral follicle count (AFC) and to diagnose PCOS [50].

In women with functional hypothalamic amenorrhea (HA) due to low body weight, the administration of kisspeptin-54 acutely stimulates secretion of gonadotropin and that the effect on gonadotropin secretion is significant after the first injection but diminishes considerably (tachyphylaxis) after injections for two weeks [51]. Nevertheless, the frequency of injections was changed from twice a day to twice a week in another study, and gonadotropin response was sustained [52]. Eight-hour intravenous infusion of kisspeptin-54 has been shown to temporarily increase LH pulse frequency and amplitude in women with hypothalamic amenorrhea [53].

Hyperprolactinemia is one of the leading causes of female infertility as it causes hypogonadotropic anovulation [54]. Since kisspeptin neurons have recently been shown to express prolactin receptors, kisspeptin has been identified as the key mediator involved in this system [55]. In mice, hyperprolactinemia causes anovulation through decreased gonadotropin and GnRH secretion and low levels of kisspeptin expression. Kisspeptin administration in these mice repairs ovarian cycle and gonadotropin secretion. It suggests that kisspeptin neurons have a role in hyperprolactinemic anovulation [56].

Endometriosis is a disease that causes infertility in women [57]. A study conducted in 2012 about endometriosis reported that Kiss1 expression could not be detected in any sample taken from endometriosis patients [58]. In one study, researchers found that the level of Kiss1 expression was statistically significantly higher in endometriosis lesions compared to the level determined in eutopic glandular endometrium and concluded that Kiss1 might have a possible role in the pathogenesis of endometriosis [59]. Another study reported that Kiss1r mRNA levels were statistically significantly higher in the cumulus cells of endometriosis patients compared to healthy oocyte donors. In consequence, researchers argue that the increased Kiss1r expression may be one of the many factors involved in the root cause of endometriosis and related infertility [60].

A study in women suffering from infertility, investigating the genetic association between the neurokinin (TAC3/TAC3R) systems and kisspeptin (Kiss1/Kiss1r) and investigating the expression of these systems, found that the expression of Kiss1, TAC3, and TAC3R was downregulated in the cumulus cells. Similarly, these three genes have been reported to be downregulated in older women with age-related infertility [60]. In that study, these findings could only be attributed to age because infertile patients were significantly older than healthy donors and because the endometriosis patients were younger and showed just an opposite expression profile compared to all other patients, including patients with age-related infertility and low responders [61].


7. Conclusion

This review has examined the association of kisspeptin with female infertility and concluded that kisspeptin has a key role in the HPG axis and can be potentially used for the treatment of reproductive disorders including hypogonadism, ovarian hyperstimulation syndrome (OHSS), polycystic ovary syndrome (PCOS), unexplained infertility (UI), male factor infertility (MFI), hypothalamic amenorrhea (HA), and endometriosis. The literature review revealed that no adverse effects were reported after kisspeptin administration in healthy individuals and patients. Therefore, kisspeptin can be used safely in both healthy and infertile individuals. Especially its positive effects on GnRH and its key role in the initiation of physiological events in the hypothalamic–pituitary-gonadal axis (HPG axis) show that kisspeptin has a say in fertility. For this reason, kisspeptin is an option that should be focused on in the solution of infertility cases that develop in mammals (humans and especially livestock) and are one of the diseases of the age.


  1. 1. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2020;113(3):533-5
  2. 2. Aflatoonian A, Baghianimoghadam B, Partovi P, Abdoli A, Hemmati P, Tabibnejad N, et al. A new classification for female infertility. Clinical and Experimental Obstetrics & Gynecology. 2011;38(4):379-381
  3. 3. Breitkopf DM, Hill M. Infertility Workup for the Women’s Health Specialist. Obstet Gynecol. 2019;133(6):e377-e384
  4. 4. Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Human Reproduction Update. 2015;21(4):411-426
  5. 5. Lee J-H, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene. JNCI J Natl Cancer Inst. 1996;88(23):1731-1737
  6. 6. Kuohung W, Kaiser UB. GPR54 and KiSS-1: Role in the regulation of puberty and reproduction. Reviews in Endocrine & Metabolic Disorders. 2007;7(4):257-263
  7. 7. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, et al. AXOR12, a Novel Human G Protein-coupled Receptor, Activated by the Peptide KiSS-1. The Journal of Biological Chemistry. 2001;276(31):28969-28975
  8. 8. de Roux N, Genin E, Carel J-C, Matsuda F, Chaussain J-L, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proceedings of the National Academy of Sciences. 2003;100(19):10972-10976
  9. 9. Kirby HR, Maguire JJ, Colledge WH, Davenport AP. International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function. Pharmacological Reviews. 2010;62(4):565-578
  10. 10. Tena-Sempere M. Kisspeptin signaling in the brain: Recent developments and future challenges. Molecular and Cellular Endocrinology. 2010;314(2):164-169
  11. 11. Funes S, Hedrick JA, Vassileva G, Markowitz L, Abbondanzo S, Golovko A, et al. The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochemical and Biophysical Research Communications. 2003;312(4):1357-1363
  12. 12. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Shagoury JK, et al. The GPR54 Gene as a Regulator of Puberty. The New England Journal of Medicine. 2003;349(17):1614-1627
  13. 13. Castellano JM, Gaytan M, Roa J, Vigo E, Navarro VM, Bellido C, et al. Expression of KiSS-1 in Rat Ovary: Putative Local Regulator of Ovulation? Endocrinology. 2006;147(10):4852-4862
  14. 14. Kauffman AS, Clifton DK, Steiner RA. Emerging ideas about kisspeptin– GPR54 signaling in the neuroendocrine regulation of reproduction. Trends in Neurosciences. 2007;30(10):504-511
  15. 15. Votsi E, Roussos D, Katsikis I, Karkanaki A, Kita M, Panidis D. Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Hippokratia. 2008;12(4):205-210
  16. 16. Xu Z, Kaga S, Mochiduki A, Tsubomizu J, Adachi S, Sakai T, et al. Immunocytochemical localization of kisspeptin neurons in the rat forebrain with special reference to sexual dimorphism and interaction with GnRH neurons. Endocrine Journal. 2012;59(2):161-171
  17. 17. Zhang P, Tang M, Zhong T, Lin Y, Zong T, Zhong C, Zhang B, Ren M, Kuang H. Expression and Function of Kisspeptin during Mouse Decidualization. Wang H, editor. PLoS One. 2014;9(5):e97647
  18. 18. Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M. Kisspeptins and Reproduction: Physiological Roles and Regulatory Mechanisms. Physiological Reviews. 2012;92(3):1235-1316
  19. 19. West A, Vojta PJ, Welch DR, Weissman BE. Chromosome Localization and Genomic Structure of the KiSS-1 Metastasis Suppressor Gene (KISS1). Genomics. 1998;54(1):145-148
  20. 20. Hameed S, Jayasena CN, Dhillo WS. Kisspeptin and fertility. The Journal of Endocrinology. 2011;208(2):97-105
  21. 21. Clarkson J, Han S-K, Liu X, Lee K, Herbison AE. Neurobiological mechanisms underlying kisspeptin activation of gonadotropin-releasing hormone (GnRH) neurons at puberty. Molecular and Cellular Endocrinology. 2010;324(1-2):45-50
  22. 22. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden J-M, Le Poul E, et al. The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54. The Journal of Biological Chemistry. 2001;276(37):34631-34636
  23. 23. Roseweir AK, Millar RP. The role of kisspeptin in the control of gonadotrophin secretion. Human Reproduction Update. 2008;15(2):203-212
  24. 24. Ke R, Ma X, Lee LTO. Understanding the functions of kisspeptin and kisspeptin receptor (Kiss1R) from clinical case studies. Peptides. 2019;120:170019
  25. 25. Colledge WH. Kisspeptins and GnRH neuronal signalling. Trends in Endocrinology and Metabolism. 2009;20(3):115-121
  26. 26. Castaño JP, Martínez-Fuentes AJ, Gutiérrez-Pascual E, Vaudry H, Tena-Sempere M, Malagón MM. Intracellular signaling pathways activated by kisspeptins through GPR54: Do multiple signals underlie function diversity? Peptides. 2009;30(1):10-15
  27. 27. d’Anglemont de Tassigny X, Colledge WH. The Role of Kisspeptin Signaling in Reproduction. Physiology. 2010;25(4):207-217
  28. 28. Gottsch ML, Cunningham MJ, Smith JT, Popa SM, Acohido BV, Crowley WF, et al. A Role for Kisspeptins in the Regulation of Gonadotropin Secretion in the Mouse. Endocrinology. 2004;145(9):4073-4077
  29. 29. Gottsch ML, Clifton DK, Steiner RA. Kisspepeptin-GPR54 signaling in the neuroendocrine reproductive axis. Molecular and Cellular Endocrinology. 2006;254-255:91-96
  30. 30. Adachi S, Yamada S, Takatsu Y, Matsui H, Kinoshita M, Takase K, et al. Involvement of Anteroventral Periventricular Metastin/Kisspeptin Neurons in Estrogen Positive Feedback Action on Luteinizing Hormone Release in Female Rats. The Journal of Reproduction and Development. 2007;53(2):367-378
  31. 31. Seminara SB. Metastin and its G protein-coupled receptor, GPR54: Critical pathway modulating GnRH secretion. Frontiers in Neuroendocrinology. 2005;26(3-4):131-138
  32. 32. Oakley AE, Clifton DK, Steiner RA. Kisspeptin Signaling in the Brain. Endocrine Reviews. 2009;30(6):713-743
  33. 33. Robertson JL, Clifton DK, de la Iglesia HO, Steiner RA, Kauffman AS. Circadian Regulation of Kiss1 Neurons: Implications for Timing the Preovulatory Gonadotropin-Releasing Hormone/Luteinizing Hormone Surge. Endocrinology. 2009;150(8):3664-3671
  34. 34. Maguire CA, Song YB, Wu M, León S, Carroll RS, Alreja M, et al. Tac1 Signaling Is Required for Sexual Maturation and Responsiveness of GnRH Neurons to Kisspeptin in the Male Mouse. Endocrinology. 2017;158(7):2319-2329
  35. 35. Han S-K. Activation of Gonadotropin-Releasing Hormone Neurons by Kisspeptin as a Neuroendocrine Switch for the Onset of Puberty. The Journal of Neuroscience. 2005;25(49):11349-11356
  36. 36. Matsui H, Takatsu Y, Kumano S, Matsumoto H, Ohtaki T. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochemical and Biophysical Research Communications. 2004;320(2):383-388
  37. 37. Navarro VM, Castellano JM, Fernández-Fernández R, Barreiro ML, Roa J, Sanchez-Criado JE, et al. Developmental and Hormonally Regulated Messenger Ribonucleic Acid Expression of KiSS-1 and Its Putative Receptor, GPR54, in Rat Hypothalamus and Potent Luteinizing Hormone-Releasing Activity of KiSS-1 Peptide. Endocrinology. 2004;145(10):4565-4574
  38. 38. Keen KL, Wegner FH, Bloom SR, Ghatei MA, Terasawa E. An Increase in Kisspeptin-54 Release Occurs with the Pubertal Increase in Luteinizing Hormone-Releasing Hormone-1 Release in the Stalk-Median Eminence of Female Rhesus Monkeys in Vivo. Endocrinology. 2008;149(8):4151-4157
  39. 39. Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM. Increased hypothalamic GPR54 signaling: A potential mechanism for initiation of puberty in primates. Proceedings of the National Academy of Sciences. 2005;102(6):2129-2134
  40. 40. Meczekalski B, Podfigurna-Stopa A, Genazzani AR. Why kisspeptin is such important for reproduction? Gynecological Endocrinology. 2011;27(1):8-13
  41. 41. Dhillo WS. Kisspeptin: A Novel Regulator of Reproductive Function. Journal of Neuroendocrinology. 2008;20(8):963-970
  42. 42. Zhou Q , Chen H, Yang S, Li Y, Wang B, Chen Y, et al. High-fat diet decreases the expression of Kiss1 mRNA and kisspeptin in the ovary, and increases ovulatory dysfunction in postpubertal female rats. Reproductive Biology and Endocrinology. 2014;12(1):127
  43. 43. Kükürt A, Kuru M, Karapehlivan M. Nitrik Oksit, Nitrik Oksit Sentaz ve Dişi Üreme Sistemindeki Rolleri. In: Evereklioğlu C, editor. Sağlık Bilimleri Alanında Akademik Çalışmalar - II. Gece Kitaplığı. 2020;2:113-123
  44. 44. Kuru M, Kükürt A, Oral H, Öğün M. Clinical Use of Progesterone and Its Relation to Oxidative Stress in Ruminants. In: Drevenšek G, editor. Sex Hormones in Neurodegenerative Processes and Diseases. InTech; 2018. pp. 303-327
  45. 45. Bedenbaugh MN, O’Connell RC, Lopez JA, McCosh RB, Goodman RL, Hileman SM. Kisspeptin, gonadotrophin-releasing hormone and oestrogen receptor α colocalise with neuronal nitric oxide synthase neurones in prepubertal female sheep. Journal of Neuroendocrinology. 2018;30(1):e12560
  46. 46. Gyurko R, Leupen S, Huang PL. Deletion of exon 6 of the neuronal nitric oxide synthase gene in mice results in hypogonadism and infertility. Endocrinology. 2002;143(7):2767-2774
  47. 47. Hanchate NK, Parkash J, Bellefontaine N, Mazur D, Colledge WH, d’Anglemont de Tassigny X, et al. Kisspeptin-GPR54 Signaling in Mouse NO-Synthesizing Neurons Participates in the Hypothalamic Control of Ovulation. The Journal of Neuroscience. 2012;32(3):932-945
  48. 48. Abbara A, Jayasena C, Comninos A, Nijher M, Christopoulos G, Izzi-Engbeaya C, et al. Kisspeptin: a novel physiological trigger for oocyte maturation in in-vitro fertilisation treatment. Lancet. 2014;383:S17
  49. 49. Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Human Reproduction Update. 2014;20(4):485-500
  50. 50. Kaya C, Alay İ, Babayeva G, Gedikbaşı A, Ertaş Kaya S, Ekin M, et al. Serum Kisspeptin levels in unexplained infertility, polycystic ovary syndrome, and male factor infertility. Gynecological Endocrinology. 2019;35(3):228-232
  51. 51. Jayasena CN, Nijher GMK, Chaudhri OB, Murphy KG, Ranger A, Lim A, et al. Subcutaneous Injection of Kisspeptin-54 Acutely Stimulates Gonadotropin Secretion in Women with Hypothalamic Amenorrhea, But Chronic Administration Causes Tachyphylaxis. The Journal of Clinical Endocrinology and Metabolism. 2009;94(11):4315-4323
  52. 52. Jayasena CN, Nijher GMK, Abbara A, Murphy KG, Lim A, Patel D, et al. Twice-Weekly Administration of Kisspeptin-54 for 8 Weeks Stimulates Release of Reproductive Hormones in Women With Hypothalamic Amenorrhea. Clinical Pharmacology and Therapeutics. 2010 Dec 27;88(6):840-847
  53. 53. Jayasena CN, Comninos AN, Narayanaswamy S, Bhalla S, Abbara A, Ganiyu-Dada Z, et al. Acute and chronic effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy women. Clinical Endocrinology. 2014;81(6):891-898
  54. 54. Molitch ME. Can prolactinomas be cured medically? Nature Reviews. Endocrinology. 2010;6(4):186-188
  55. 55. Kokay IC, Petersen SL, Grattan DR. Identification of Prolactin-Sensitive GABA and Kisspeptin Neurons in Regions of the Rat Hypothalamus Involved in the Control of Fertility. Endocrinology. 2011;152(2):526-535
  56. 56. Sonigo C, Bouilly J, Carré N, Tolle V, Caraty A, Tello J, et al. Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. The Journal of Clinical Investigation. 2012;122(10):3791-3795
  57. 57. Fuldeore MJ, Soliman AM. Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women. Gynecologic and Obstetric Investigation. 2017;82(5):453-461
  58. 58. Alian S, Ahangarkani F, Arabsheybani S. A Case of Orf Disease Complicated with Erythema Multiforme and Bullous Pemphigoid-Like Eruptions. Case Rep Infect Dis. 2015;2015:1-4
  59. 59. Timologou A, Zafrakas M, Grimbizis G, Miliaras D, Kotronis K, Stamatopoulos P, et al. Immunohistochemical expression pattern of metastasis suppressors KAI1 and KISS1 in endometriosis and normal endometrium. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2016;199:110-115
  60. 60. Blasco V, Pinto FM, Fernández-Atucha A, González-Ravina C, Fernández-Sánchez M, Candenas L. Female infertility is associated with an altered expression of the neurokinin B/neurokinin B receptor and kisspeptin/kisspeptin receptor systems in ovarian granulosa and cumulus cells. Fertility and Sterility. 2020;114(4):869-878
  61. 61. Chatzicharalampous C. A genetic association study of kisspeptin 1/ neurokinin B systems in patients with infertility: Is it that simple? Fertility and Sterility. 2020;114(4):762-763

Written By

Abdulsamed Kükürt, Mushap Kuru, Ömer Faruk Başer and Mahmut Karapehlivan

Submitted: 26 October 2020 Reviewed: 05 November 2020 Published: 23 November 2020